Ospedale Regionale di Lugano
About Ospedale Regionale di Lugano
"L'Ospedale Regionale di Lugano ha due sedi (Civico e Italiano) ed è un ospedale pubblico polispecialistico dotato di moderne infrastrutture e di una tecnologia medica all'avanguardia."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
4
Christian Candrian
4
Biogen
3
Fondazione Epatocentro Ticino
3
Swiss Group for Clinical Cancer Research
3
University Hospital Inselspital, Berne
3
Boston Scientific Corporation
2
Claudio Gobbi
2
ETOP IBCSG Partners Foundation
2
Fabio Garofalo
2
Miracor Medical SA
2
Clinical Trials at Ospedale Regionale di Lugano
During the past decade, Ospedale Regionale di Lugano conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 7 clinical trials were completed, i.e. on
average, 16.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 5 clinical trials were completed. i.e. 26.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
1999-08-30
2022-03-31
Terminated
175
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer
2003-03-01
2010-05-01
Completed
66
Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
2004-06-01
2006-02-01
Completed
74
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
2007-08-01
2019-05-15
Completed
4,884
Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure
2008-02-01
2015-06-01
Completed
1,325
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
2012-08-01
2015-06-01
Completed
312
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ospedale Regionale di Lugano" #1 sponsor was "Bayer" with 4 trials, followed by "Christian Candrian" with 4 trials
sponsored, "Biogen" with 3 trials sponsored, "Fondazione Epatocentro Ticino" with 3 trials sponsored and "Swiss Group for Clinical Cancer Research"
with 3 trials sponsored. Other sponsors include 38 different institutions and
companies that sponsored additional 37 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Regionale di Lugano"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Ospedale Regionale di Lugano" with 2 trials as a collaborator, "University Hospital, Basel, Switzerland" with 2 trials as a collaborator, "University of Lausanne Hospitals" with 2 trials as a collaborator and "Australasian Kidney Trials Network" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were
collaborators in the rest 33 trials.
Clinical Trials Conditions at Ospedale Regionale di Lugano
According to Clinical.Site data, the most researched conditions in "Ospedale Regionale di Lugano" are
"Breast Cancer" (3 trials), "Multiple Sclerosis" (3 trials), "Alzheimer's Disease" (2 trials), "Heart Failure" (2 trials) and "Subarachnoid Hemorrhage" (2 trials). Many other conditions were trialed in "Ospedale Regionale di Lugano" in a lesser frequency.
Clinical Trials Intervention Types at Ospedale Regionale di Lugano
Most popular intervention types in "Ospedale Regionale di Lugano" are "Drug" (21 trials), "Device" (17 trials), "Other" (10 trials) and "Procedure" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "BAY2433334" (3 trials), "BAY2433334 matching placebo" (3 trials), ""white" test" (= the administration of SMOFlipid retrograde through the cystic duct)" (1 trials) and "Abdominal" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ospedale Regionale di Lugano
The vast majority of trials in "Ospedale Regionale di Lugano" are
56 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Ospedale Regionale di Lugano
Currently, there are NaN active trials in "Ospedale Regionale di Lugano".
undefined are not yet recruiting,
19 are recruiting,
5 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 20 completed trials in Ospedale Regionale di Lugano,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale Regionale di Lugano, 0 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 17 trials that are defined as “Not Applicable".